rs786204472
Variant summary
Our verdict is Pathogenic. Variant got 18 ACMG points: 18P and 0B. PVS1PM2PP5_Very_Strong
The NM_005562.3(LAMC2):c.667C>T(p.Arg223Ter) variant causes a stop gained change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000205 in 1,461,846 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★★). Variant results in nonsense mediated mRNA decay.
Frequency
Consequence
NM_005562.3 stop_gained
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 18 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
LAMC2 | NM_005562.3 | c.667C>T | p.Arg223Ter | stop_gained | 6/23 | ENST00000264144.5 | NP_005553.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
LAMC2 | ENST00000264144.5 | c.667C>T | p.Arg223Ter | stop_gained | 6/23 | 1 | NM_005562.3 | ENSP00000264144 | P1 | |
LAMC2 | ENST00000493293.5 | c.667C>T | p.Arg223Ter | stop_gained | 6/22 | 1 | ENSP00000432063 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD3 exomes AF: 0.00000398 AC: 1AN: 251492Hom.: 0 AF XY: 0.00 AC XY: 0AN XY: 135918
GnomAD4 exome AF: 0.00000205 AC: 3AN: 1461846Hom.: 0 Cov.: 32 AF XY: 0.00 AC XY: 0AN XY: 727226
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
Junctional epidermolysis bullosa gravis of Herlitz Pathogenic:2
Pathogenic, criteria provided, single submitter | clinical testing | Women's Health and Genetics/Laboratory Corporation of America, LabCorp | Apr 22, 2019 | Variant summary: LAMC2 c.667C>T (p.Arg223X) results in a premature termination codon, predicted to cause a truncation of the encoded protein or absence of the protein due to nonsense mediated decay, which are commonly known mechanisms for disease. Truncations downstream of this position have reported in patients in the literature (HGMD). The variant allele was found at a frequency of 4e-06 in 251492 control chromosomes (gnomAD). c.667C>T has been reported in the literature in a compound heterozygous patient who was affected by the most severe, Herlitz type of Junctional Epidermolysis Bullosa (Posteraro 2004, Castori 2008). One of these publications also reported that northern blot analysis of the patients RNA indicated the lack of WT mRNA, furthermore, the patient was negative for laminin-5 staining by immunofluorescence and had rudimentary hemidesmosomes by transmission electron microscopy (Posteraro 2004). No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar after 2014. Based on the evidence outlined above, the variant was classified as pathogenic. - |
Likely pathogenic, criteria provided, single submitter | literature only | Counsyl | May 20, 2014 | - - |
not provided Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Aug 30, 2023 | ClinVar contains an entry for this variant (Variation ID: 188791). For these reasons, this variant has been classified as Pathogenic. This premature translational stop signal has been observed in individual(s) with junctional epidermolysis bullosa (PMID: 15373767). This variant is present in population databases (rs753268823, gnomAD 0.0009%). This sequence change creates a premature translational stop signal (p.Arg223*) in the LAMC2 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in LAMC2 are known to be pathogenic (PMID: 11907499, 16473856). - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at